	Process evaluation of a hybrid effectiveness-implementation, pragmatic, cluster randomised controlled trial (IMPULSE) to improve psychosocial treatment of patients with psychotic-spectrum disorders in Southeast Europe. PLoS One Pemovska T, Jovanovi, Radoji, Markovska Simoska S, Ramadani F, Andri, Karamehi, Blazhevska Stoilkovska B, Konjufca J, Jeroti, D, Injac Stevovi, Francis JJ. PMID: 41637446 [PubMed - indexed for MEDLINE]
	Psychological and Psychosocial Interventions for People With Schizophrenia and Co-Occurring Substance Use Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry Salahuddin NH, Herlitzius E, Schütz A, Siafis S, Priller J, Leucht S, Bighelli I. PMID: 41637064 [PubMed - as supplied by publisher]
	Correction: Low-dose paliperidone combined with sertraline for first-episode and medication-naÃ¯ve patients with schizophrenia: an open-label, randomized trial. Eur Arch Psychiatry Clin Neurosci Lin Z, Guan X, Lang X, Xiu M, Wu F. PMID: 41636821 [PubMed - as supplied by publisher]
	Exploration of barriers and facilitators to physical activity in adults with schizophrenia involved in a long-term psychosocial rehabilitation programme: a mixed method study. Int J Psychiatry Clin Pract Augustin A, Gruet M, Chalabaev A, Mulin E. PMID: 41636361 [PubMed - as supplied by publisher]
	Commentary: Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia: qualitative results from the multinational ADVANCE study. Front Psychiatry Oguchi Y. PMID: 41635630 [PubMed]
	Resting-state gamma power in schizophrenia: a systematic review and meta-analysis. Front Psychiatry Liu Y, Xu P, Hu S. PMID: 41635520 [PubMed]
	Differences in height, weight, and BMI in patients with mood disorders, schizophrenia, and other mental disorders vs. normal controls. Front Psychiatry Fountoulakis KN, Petalidou N, Fountoulakis NK, Nimatoudis I, Theodorakis PN. PMID: 41635519 [PubMed]
	Mindfulness and psychotic-like experiences in nonclinical populations: a systematic review and two meta-analyses. Psychol Med Mysko K, Gear EQ, Ellett L. PMID: 41634965 [PubMed - indexed for MEDLINE]
	Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial. Am J Psychiatry Kaul I, Claxton A, Sauder C, Patel T, Chaturvedi S, Brown D, Zhu H, Marcus R, Sawchak S, Brannan SK. PMID: 41634905 [PubMed - as supplied by publisher]
	A systematic review and meta-analysis of the auditory steady-state response in schizophrenia, bipolar disorder, and autism spectrum disorder. Mol Psychiatry Kinjo M, Tamura S, Sugiyama S, van Weert E, Oribe N, Tsuchimoto R, Mitoma R, Takai Y, Honda S, Nakajima S, Hirano Y, Uhlhaas PJ, Noda Y. PMID: 41634135 [PubMed - as supplied by publisher]
	Targeting muscarinic receptors for treating schizophrenia. Neurotherapeutics Paul SM, Yohn SE. PMID: 41633901 [PubMed - as supplied by publisher]
	Evaluation and Treatment Considerations for Children and Adolescents Presenting With Psychosis Symptoms in Primary Care. Pediatr Ann Warner C, Reznik S, Fitzgerald J. PMID: 41633548 [PubMed - indexed for MEDLINE]
	Guideline-Concordant Care and Clinician and Clinic Characteristics for Patients With Schizophrenia. JAMA Netw Open Chen AY, Simon GE, Ericson KM, Zeber JE, Qian J, Geissler KH. PMID: 41632161 [PubMed - indexed for MEDLINE]
	Olanzapine in the treatment of schizophrenia in adolescents - mechanisms of action and therapeutic efficacy. Psychiatr Pol Nowak W, Korba P, Kinalska N, Kubik J, Lizo, Krzy. PMID: 41630413 [PubMed - indexed for MEDLINE]
	Living with psychosis and cognitive impairment: a qualitative study. BMC Psychiatry Landström T, Björkdahl A, Tyrberg MJ, Lindau M. PMID: 41629854 [PubMed - as supplied by publisher]
	Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [(11)C]UCB-J positron emission tomography study. Neuropsychopharmacology Onwordi EC, Whitehurst T, Shatalina E, Mansur A, Arumuham A, Osugo M, Marques TR, Jauhar S, Mehrotra R, Ranger M, Rahaman N, Church SM, Rabiner EA, Gunn RN, Natesan S, Reichenberg A, Howes OD. PMID: 41629634 [PubMed - as supplied by publisher]
	Analysis and prediction of schizophrenia patients based on high-order graph attention generative adversarial networks. Sci Rep Yin G, Yin M, Guo G, Yuan J, Ma X, Wang L, Zhao P, Shi D, Zhao Y, Zhao Z, Wang B, Tan S. PMID: 41629367 [PubMed - indexed for MEDLINE]
	Untargeted (1)H NMR-based metabolomics unveils distinct circulating biochemical signatures between treatment-resistant and non-treatment-resistant schizophrenia patients: a pilot study. Transl Psychiatry Marino C, Zhang S, De Simone G, Grimaldi M, Di Maio A, Iasevoli F, Errico F, D'Ursi AM, de Bartolomeis A, Usiello A. PMID: 41629277 [PubMed - as supplied by publisher]
	Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada. CMAJ Myran DT, Gibb M, Pugliese M, Fiedorowicz JG, Anderson KK, Ramsay T, Jalal H, Kurdyak P, Solmi M. PMID: 41628942 [PubMed - indexed for MEDLINE]
	Episodic future thinking intervention in schizophrenia patients: Effects and neural correlates. Neuropsychologia Liu JL, Ye JY, Yang TX, Cui JF, Lai WH, He YL, Zhang P, Jiang ZJ, Chen T, Lui SSY, Chen GF, Zhang TJ, Wang Y, Chan RCK. PMID: 41628852 [PubMed - as supplied by publisher]

Articles 1 - 20 / 67951

Page 1 of 3398



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy